logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/09/2026
Novo Nordisk: "Novo" will serve as the company's generic name; Novo Nordisk A/S remains the legal name. Novo Nordisk - will adopt "NOVO" as the company name; Novo Nordisk A/S remains the legal name.
Latest
2 m ago
Market news: This week, the Federal Reserve, the Bank of England, and the Bank of Japan will successively announce their latest interest rate decisions. Some industry insiders are now worried that a synchronized tightening by the three major central banks of the US, Japan, and Europeunseen in two decadescould, like dominoes, rapidly spread an aggressive hawkish stance across the entire G10 economies.
2 m ago
HK Stock Movement | Peijia Medical-B (09996.HK) Rises Over 3% as Registration Application for GeminiOne Transcatheter Edge-to-Edge Repair System Approved by National Medical Products Administration
3 m ago
Italian Technoprobe shares extend losses, now down 7.8%.
4 m ago
State-owned Assets Supervision and Administration Commission of the State Council: Central enterprises take the lead in paying accounts in a timely manner.
5 m ago
Goldman Sachs: Raises target price for Sino Biopharmaceutical (01177.HK) to HK$9.07, reiterates "Buy" rating.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.